Experts Raise Questions About Vioxx Decision
905
Two leading heart experts called for  urgent investigations on Wednesday into whether all painkilling  drugs known as COX-2 inhibitors may raise the risk of heart  attack in some people.
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
507619
FDA researchers say taking high doses of arthritis drug can raise risk of heart attacks. WASHINGTON -- The nation&#39;s largest health management organization is considering changing how it prescribes Vioxx after
306536
TORONTO (CP) - In the wake of last week&#39;s surprise market withdrawal of wonder drug Vioxx, scientists Wednesday questioned the safety of the entire class of arthritis drugs known as Cox-2 inhibitors.
387871
Oct. 6, 2004 - Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
31437
The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened concern over drug safety that valuable medicines could be kept from patients, doctors said on Friday.
365737
The safety of Merck&#39;s (MRK:NYSE - news - research) Vioxx has been questioned again with the posting of an internal Food and Drug Administration study on the agency&#39;s website.
131994
Doctors are struggling to decide which pain relievers to prescribe now that they know that drugs like Vioxx and Celebrex pose serious heart risks.
440274
Congress has been investigating the FDA&#39;s decisions in both the Vioxx and antidepressant cases. The probes have focused on agency reviewers who warned about potential problems but claimed their research was ignored or suppressed by other officials.
596898
Two US regulators defended the Food and Drug Administration's handling of the withdrawn painkiller Vioxx, disputing the contention of heart researcher Dr. Eric Topol that the agency could have forced Merck &amp; Co. to do more safety testing.
735299
WASHINGTON -- The nation&#39;s largest health management organization is considering changing how it prescribes Vioxx after a government study showed that high doses of the arthritis drug tripled patients&#39; risk of heart attacks and sudden cardiac death.
284993
Doctors have been taking calls from anxious patients ever since a Senate hearing on Vioxx last week at which an FDA scientist expressed concerns about the safety of five other drugs on the market.
392614
Amidst recent prescription drug recalls, health experts have tips for patients to determine the safety of their medications. Merck Pharmaceuticals&#39; September decision to withdraw its widely used arthritis
106185
A SENIOR regulator whose investigation into Vioxx prompted Merck to pull the painkiller from pharmacy shelves raised doubts yesterday over the safety of five other big-selling medicines.
12098
Cleveland Clinic cardiologist Eric Topol was one of the first to point out the potential heart risk of Merck&#39;s (nyse: MRK - news - people ) withdrawn Vioxx and Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
321009
Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
237814
Merck (MRK) officials on Wednesday called a press conference to reiterate that they did not believe until last month that Vioxx raised users&#39; risk of heart attacks or strokes.